<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>It has been suggested that <z:chebi fb="131" ids="25107">magnesium</z:chebi> (Mg) may play a role in the pathogenesis of <z:hpo ids='HP_0002315'>headaches</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>Serum and intracellular measurements of Mg in <z:hpo ids='HP_0002315'>headache</z:hpo> patients have produced inconsistent results </plain></SENT>
<SENT sid="2" pm="."><plain>The recent development of an ion-selective electrode for Mg2+ allowed precise measurement of serum ionized <z:chebi fb="131" ids="25107">magnesium</z:chebi> (IMg2+) in patients with various <z:hpo ids='HP_0002315'>headache</z:hpo> syndromes </plain></SENT>
<SENT sid="3" pm="."><plain>Low serum IMg2+ and a high ICa2+/IMg2+ ratio were found in 42% of patients having an attack of <z:hpo ids='HP_0002076'>migraine</z:hpo>, but only in 23% of patients with a severe continuous <z:hpo ids='HP_0002315'>headache</z:hpo> </plain></SENT>
<SENT sid="4" pm="."><plain>Total serum Mg was <z:mpath ids='MPATH_458'>normal</z:mpath> in both groups of patients </plain></SENT>
<SENT sid="5" pm="."><plain>However, in patients with low serum IMg2+ total serum Mg was lower than in patients with <z:mpath ids='MPATH_458'>normal</z:mpath> serum IMg2+ </plain></SENT>
<SENT sid="6" pm="."><plain>These results are compatible with the <z:chebi fb="19" ids="28790">serotonin</z:chebi> and vascular concepts of <z:hpo ids='HP_0002076'>migraine</z:hpo> pathogenesis </plain></SENT>
<SENT sid="7" pm="."><plain>Low IMg2+ and a high ICa2+/IMg2+ would result in <z:e sem="disease" ids="C0265110" disease_type="Disease or Syndrome" abbrv="">cerebral vasospasm</z:e> and reduced blood flow in the brain </plain></SENT>
<SENT sid="8" pm="."><plain>The activity of <z:chebi fb="19" ids="28790">serotonin</z:chebi> receptors can also be affected by changes in IMg2+ levels </plain></SENT>
<SENT sid="9" pm="."><plain>The finding of a difference in IMg2+ levels in two different <z:hpo ids='HP_0002315'>headache</z:hpo> types suggests a possible novel classification of <z:hpo ids='HP_0002315'>headaches</z:hpo> and that <z:hpo ids='HP_0002076'>migraine</z:hpo> patients with a low serum IMg2+ or a high ICa2+/IMg2+ ratio may benefit from Mg supplementation </plain></SENT>
</text></document>